RDCRN Home | View All Open Studies

Pulling it all together.

Immune mediated disorders develop in 50% of allogeneic
hematopoietic cell transplant recipients and are major
causes of suffering and treatment-related complications.

Collaboration between patients and researchers can help us
better understand and treat these disorders

 
Information for Patients and Families

Diseases Defined:

  • Cutaneous Sclerosis
  • Bronchiolitis Obliterans
  • Late Acute Graft versus Host Disease
  • Chronic Graft versus Host Disease

Medical Glossary

Advocacy: Find patient groups and national organizations

Let Us Notify You of cGVHD Research!

Research Studies

  • Comparing Treatments for Cutaneous Sclerosis
  • Comparing Treatments for Bronchiolitis Obliterans
Information for Professionals

In Depth:

  • Graft Versus Host Disease Information for Medical Professionals

Finding Answers: How to Contribute to cGVHD research

cGVHD Research: Refer Patients for Clinical Research Studies

Participating Clinical Centers

Events and Training


What is the cGVHD Consortium? | cGVHD Consortium Contact Information | Contact the Web Master | Accessibility | Disclaimer

Department of Health and Human ServicesDepartment of Health and Human Services

National Institutes of HealthNational Institutes of Health

 Office of Rare Diseases Research

National Institute of Allergy and Infectious DiseasesNational Cancer Institute

RDCRN Research Members Login

The Chronic Graft Versus Host Disease Consortium (cGVHD) is a part of NIH Rare Diseases Clinical Research Network (RDCRN). Funding and/or programmatic support for this project has been provided by the National Cancer Institute (NCI) and the NIH Office of Rare Diseases Research (ORDR). The views expressed in written materials or publications do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Read Disclaimer >